We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Paxil May Increase Birth Defect Risk, GSK Letter Warns
Paxil May Increase Birth Defect Risk, GSK Letter Warns
September 30, 2005
A new epidemiologic study of GlaxoSmithKline’s (GSK) top-selling antidepressant Paxil suggests the drug may be associated with an increased risk of birth defects compared to other antidepressants, GSK states in a recently issued “Dear Healthcare Professional” letter.